SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $141,000 | – | 22,195 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopernik Global Investors, LLC | 664,747 | $6,600,000 | 3.63% |
| MAK CAPITAL ONE LLC | 1,199,865 | $11,915,000 | 2.55% |
| NEWGATE CAPITAL MANAGEMENT LLC | 876,843 | $8,707,000 | 1.94% |
| Global X Management CO LLC | 1,390,647 | $13,809,000 | 0.94% |
| VAN ECK ASSOCIATES CORP | 12,214,400 | $121,289,000 | 0.60% |
| ALGERT GLOBAL LLC | 49,590 | $493,000 | 0.20% |
| ROYCE & ASSOCIATES LP | 5,248,680 | $52,119,000 | 0.15% |
| Connor, Clark & Lunn Investment Management Ltd. | 1,866,000 | $20,470,000 | 0.15% |
| Tradewinds Global Investors, LLC | 535,755 | $5,320,000 | 0.13% |
| Harbour Capital Advisors, LLC | 10,910 | $108,000 | 0.10% |